The use of methyluracil and levamisole in patients with diabetes mellitus
T. V. Morugova
Kazan medical journal ›› 1982, Vol. 63 ›› Issue (2) : 35 -37.
The use of methyluracil and levamisole in patients with diabetes mellitus
The inclusion of methyluracil in the complex treatment of patients with diabetes mellitus leads to a more pronounced increase in the phagocytic index and a slight increase in the titers of natural agglutinins and antibodies to alpha-staphyllisin. Levamisole significantly increases the content of T-lymphocytes. As a stimulant of immunity in diabetes mellitus, it is more advisable to use methyluracil, which is an anabolic and antioxidant.
diabetes / immunity / methyluracil / levamisole / Kazan Medical archiv
| [1] |
Камилов Ф. X. В кн.: Биохимическая фармакология некоторых пиримидиновых производных и вопросы лекарственной стимуляции иммуногенеза. Челябинск,. 1969 |
| [2] |
Кендыш И. Н. Пробл. эндокринол., 1980, 4. |
| [3] |
Лифшиц Р. И. В кн.: Неспецифческая лекарственная профилактика и терапия рака. Л., 1966. |
| [4] |
Кrthаrа М., Еуrе Н. G. а. о. Diabetes, 1980, 29, 4. |
Morugova T.V.
/
| 〈 |
|
〉 |
PDF
